Skip to main content

Table 1 PrPSc abundance and prion seeding activity in CJD brain homogenate samples inoculated into transgenic mice

From: Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes

Case #a

Subtypea

PrPSc (SpC)b

SD50/gc

Control

MM1

ND

>  5 × 109

3

MV1 + 2C

280 ± 103

5 × 109

4

MV1 + 2C

48 ± 9

9 × 107

9 CC

MV2K + 2C

56 ± 12

8.9 × 1010

9 CbC

MV2K + 2C

126 ± 15

2.8 × 1010

12

MV2K + 2C

90 ± 4

1.6 × 109

19 (iCJD)

MV2K

133 ± 19

3.5 × 1011

10

MV2K

175 ± 19

1.2 × 1011

20 (iCJD)

MV2K

171 + 44

1.6 × 1011

7

MV2K

581 ± 89

2.8 × 1011

18 (iCJD)

MV2K

65 ± 7

2.8 × 1011

11

MV2C

290 ± 9

3.4 × 1010

  1. aNeuropathological subtype of cases originally described in [28]. All cases are sCJD except where noted as iCJD. CC cerebral cortex, CbC cerebellar cortex
  2. bSpC spectral counts. Total number of PrPSc peptides as determined by mass spectrometry of phosphotungstic acid precipitated CJD brain material For mean + standard deviation in previous sentence, please underline the + sign. are adapted from [28]
  3. cSD50/g = prion seeding doses (SD) yielding 50% positive wells in replicate RT-QuIC reactions per 1 g of MV brain homogenate [45]. Values were calculated from 3 independent end-point titration experiments